Nectar Lifesciences Limited @ 28.50

1. Nectar Lifesciences Limited is a 1 rupee face value pharmaceutical company currently traded at 28.50.

2. Nectar Lifesciences Limited BSE CODE:-532649 ID:-NECLIFE and NSE CODE:-NECLIFE ISIN:-INE023H01027.

3. Year High of  Nectar Lifesciences Limited is 41.75 (On 08.01.2018) and year low18.70 (On 05.06.2018). Year High/Year Low ratio of the stock is 2.23, generally, I accept stocks which year high/low ratio is below 2 but if the company post good results then this ratio will be accepted till 2.5.

So due to June 18 good results where Q on Q profit rises from 3.89 Cr to 13.21 Cr. 

New visitors please read my stock market books or read my equity research terms or watch my video to learn more about my research terms, here I provided links for more details:-

Equity Research Terms of Mahesh Kaushik

Video About Year High/Low Effect of Stock Selection

Mahesh Kaushik Stock Market Books In English or Hindi

4. After Making Year low 18.70 on 05 June 2018 stock of Nectar Lifesciences Limited is turn around and on 31 Aug 2018 it gives a breakout over his 200 DMA and currently traded above his 30,50,150, and 200 DMA

Simple Moving Averages

DAYS	BSE	NSE
30	23.22	23.20
50	22.66	22.63
150	26.12	26.11
200	28.32	28.31

5. Base Price of Nectar Lifesciences Limited is 34.76 so stock traded 18% below from base price so this stock fulfills my stock selection terms on basis of base price.

You can download last 3-year price data and graph from this link:-

Nector Life Sciences 3 Year Price Data and Graph

6. Net sale per share of this stock is 84.73 which is near 3 times higher from the current market price.

7. Book Value of Nectar Lifesciences Limited is 47.21

8. Target:- The fundamental target price of Nectar Lifesciences Limited is 50.00, we can buy this stock for 1 months to 3 months time horizon our 1st target is 34.20 which is 20% above from CMP, our 2nd target is 50.00 which is fundamental target price of this stock, our 3rd target is 84.75 which is net sale per share of this company if you want to learn how to calculate fundamental target price ? then please watch this video:-Video Fundamental Target Price of Stocks

after achieving 1st target hold with trailing stop loss which shown in my art of profit booking video.

Stop Loss:-22.60 is our stop loss ( Close below 50 DMA treated as the stop loss for 1 to 3 months time frame)

9. Negative Point:-Promoters hold 55.80% stocks but promoters pledged 21.11% stocks and due to these 21.11 %pledged stocks I do not include this recommendation on my homepage http://www.maheshkaushik.com but in this blog, we consider trading stocks for 1 months to 3 months time frame where I allow stocks up to 33% promoters pledged stocks.

10. Dividend:-Yes Nectar Lifesciences Ltd is a dividend paying company here is dividend history:-

EX Date	Purpose
19/09/2018	Final Dividend 0.05
20/09/2017	Final Dividend 0.05
22/09/2016	Final Dividend 0.10
22/09/2015	Final Dividend 0.10
21/08/2014	Final Dividend 0.10

11. No bulk deals, block deals, bonus issue, stock split, right issue etc. shown in last 2 year which is a good point.

12. Recent Update:-शेयर बाजार में आयकर की खेती अर्थात इन्कम टैक्स हार्वेस्टिंग क्या है? What is Income Tax Harvesting In Stock Market?

12. Disclaimer:- This is not an advisory service to buy or sell. The contents of “this research report” are only for educational purposes. No liability is accepted for any content in “this research report.” The author is a registered research analyst but he does not give investment advice. His comments are an expression of opinion only and should not be construed in any manner whatsoever as recommendations to buy or sell a stock, option, future, bond, commodity, index or any other financial instrument at any time. The author recommends that you consult with a qualified investment advisor, one licensed by appropriate regulatory agencies in your legal jurisdiction, before making any investment decisions. Please read the full disclaimer at the bottom of my blog. 

13.Discloser:- I Mahesh Chander Kaushik author of this research report is an existing research analyst and passed NISM certification for research analysts. I am also registered with SEBI(RESEARCH ANALYSTS) Regulations, 2014 ( SEBI Registration Number INH 100000908 ) hereby disclose about my financial interest in the subject company and the nature of such financial interest:- 1 Me and my associates or relatives have not held any share of Nectar Lifesciences Ltd so my personal interest is not included in this stock. 2. Me and my associates or relatives have not any actual/beneficial ownership of one percent or more securities of the subject company ( Nectar Lifesciences Ltd). 3. Me and my associates or relatives have not any other material conflict of interest at the time of publication of the research report. 4. Me and my associates or relatives have not received any type of compensation from the subject company(Nectar Lifesciences Ltd) in the past twelve months. 5. I am not served as an officer, director or employee of the subject company ( Nectar Lifesciences Ltd). 6. I have been not engaged in market making activity for the subject company (Nectar Lifesciences Ltd).